A novel DYRK1A (dual specificity tyrosine phosphorylation-regulated kinase 1A) inhibitor for the treatment of Alzheimer's disease: effect on Tau and amyloid pathologies in vitro. (Q42702995)
Jump to navigation
Jump to search
scientific article published on 26 January 2015
Language | Label | Description | Also known as |
---|---|---|---|
English | A novel DYRK1A (dual specificity tyrosine phosphorylation-regulated kinase 1A) inhibitor for the treatment of Alzheimer's disease: effect on Tau and amyloid pathologies in vitro. |
scientific article published on 26 January 2015 |
Statements
A novel DYRK1A (dual specificity tyrosine phosphorylation-regulated kinase 1A) inhibitor for the treatment of Alzheimer's disease: effect on Tau and amyloid pathologies in vitro (English)
1 reference
Séverine Coutadeur
Hélène Benyamine
Laurence Delalonde
Catherine de Oliveira
Alicia Foucourt
Anne-Sophie Casagrande
Thierry Taverne
Angélique Girard
Matthew P Pando
Laurent Désiré
26 January 2015
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference